Archana Narasanna

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Shizhen Emily Wang, Archana Narasanna, Marianela Pérez-Torres et al. · Cancer Cell · 2006 · 464 citations · Full text

Signal Transduction, Signaling Pathway, Cell Regulation +8

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez et al. · Journal of Clinical Oncology · 2010 · 256 citations

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang et al. · Cancer Research · 2011 · 223 citations · Full text

Breast Oncology, Her2 Homodimers, Immunology +17

α‐Synuclein produces a long‐lasting increase in neurotransmitter release

Shumin Liu, Ipe Ninan, Irina Antonova et al. · The EMBO Journal · 2004 · 188 citations · Full text

Loss of <i>Phosphatase and Tensin Homologue Deleted on Chromosome 10</i> Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer

Todd W. Miller, Marianela Pérez-Torres, Archana Narasanna et al. · Cancer Research · 2009 · 169 citations · Full text

Breast Oncology, Estrogen Receptor, Chromosome 10 +19